BioSpace News Archive

Business

EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors

EDAP TMS SA, the global leader in robotic energy-based therapies, announced the appointment of Lance Willsey, M.S., M.D. to its Board of Directors.

December 6, 2023
·
3 min read
Biotech Bay

89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants - December 06, 2023

89bio, Inc. announced that it has commenced an underwritten public offering of $125.0 million of shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock.

December 6, 2023
·
5 min read
Telo Genomics Gears up for American Society of Hematology Conference

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the “Company” or “Telo”), an emerging molecular testing platform provider leveraging the power of telomeres, looks forward to attending the American Society of Hematology (ASH) annual meeting in San Diego this week.

December 6, 2023
·
4 min read
Job Trends

Press Release: Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster Launches, Paving the Way to Industry Leadership in Immunology

Sanofi is hosting an Investor R&D Event in New York providing updates and insight into its innovative pipeline and new growth drivers.

December 6, 2023
·
8 min read
ZyVersa Therapeutics Announces Publication Showing AIM2 and NLRP3 Inflammasomes Promote Atherosclerosis in Diabetes, Supporting IC 100’s Rationale for Targeting ASC to Inhibit Multiple Inflammasome Pathways

ZyVersa Therapeutics, Inc. announces publication of an article in the peer-reviewed journal, Diabetes, demonstrating that AIM2 and NLRP3 inflammasome activation contributes to development of atherosclerosis in two different animal models of type 1 diabetes.

December 6, 2023
·
6 min read
Drug Development

Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus

Century Therapeutics today announced that the Company has been notified by the U.S. Food and Drug Administration (FDA) that the Company’s Phase 1 clinical trial may proceed to assess CNTY-101.

December 6, 2023
·
9 min read
Deals

Danaher Completes Acquisition of Abcam

Danaher Corporation (NYSE:DHR) (“Danaher”) announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) (“Abcam”).

December 6, 2023
·
1 min read
Business

Stryker announces Dr. Srikant Datar will retire from Board of Directors

Stryker (NYSE:SYK) announced today that after 15 years of distinguished service, Dr. Srikant Datar has notified the Company that he will not stand for re-election at Stryker’s 2024 Annual Meeting of Shareholders, which is expected to be held on May 9, 2024.

December 6, 2023
·
2 min read
Biotech Beach

Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays

Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced it has begun the FDA single-site process for its VitaGraft transplant assays.

December 6, 2023
·
5 min read
Business

Outlook Therapeutics® Announces Strategic Organizational Realignment

Outlook Therapeutics, Inc. today announced a realignment of resources.

December 6, 2023
·
6 min read